Journals / Androloji Bülteni / 2018 / Cilt: 20 - Sayı: 3

Hyperprolactinemia and erectile dysfunction

Hiperprolaktinemi ve erektil disfonksiyon

Pages
90–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, measurement of serum prolactin levels in patients with erectile dysfunction, especially those with low testosterone, is an important test that must be kept in mind.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Prolactin is a hormone that is synthesized and released in systemic circulation from the anterior pituitary gland.
📊
Key Findings & Data:In patients with hyperprolactinemia, treatment is possible with dopamine agonists about 90% of the patients.
💡
Conclusion & Impact:Therefore, measurement of serum prolactin levels in patients with erectile dysfunction, especially those with low testosterone, is an important test that must be kept in mind.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Prolactin is a hormone that is synthesized and released in systemic circulation from the anterior pituitary gland. Excessive prolactin release can be associated with some findings, especially loss of libido, infertility, and erectile dysfunction (ED) in men. Although hyperprolactinemia is a rare condition, it is a correctable cause of male sexual dysfunction. In patients with hyperprolactinemia, treatment is possible with dopamine agonists about 90% of the patients. Therefore, measurement of serum prolactin levels in patients with erectile dysfunction, especially those with low testosterone, is an important test that must be kept in mind.

Özet

Prolaktin ön hipofizden sentezlenerek dolaşıma katılan bir hormondur. Prolaktinin aşırı salınımı erkeklerde başta infertilite ve erektil disfonksiyon (ED) olmak üzere birtakım bulgular ile karşımıza çıkabilmektedir. Hiperprolaktinemi nadir görülen bir durum olmasına karşın erkek cinsel fonksiyon bozukluğunun düzeltilebilir bir nedenidir. Hiperprolaktinemi saptanan hastalarda dopamin agonistleri ile yaklaşık %90 oranlarında tedavi mümkündür. Bu nedenle, özellikle testosteron düşüklüğü olan erektil disfonksiyonlu hastalarda serum prolaktin düzeyi ölçümü akılda tutulması gereken, önemli bir testtir. Sağlık Bilimleri Üniversitesi, Ankara Numune Eğitim ve Araştırma Hastanesi, Üroloji A Kliniği, Ankara, Türkiye

🔖

Cite This Article

GÜZEL, Ö., ATAN, A., ASLAN, Y. (2018). Hyperprolactinemia and erectile dysfunction. Androloji Bülteni, Cilt: 20 - Sayı: 3, 90–94. https://ajindex.com/articles/146145

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Becker KL, Kahn CR, Rebar RW. Prolactin and its disorders. Chapter 13. Principles and Practice of Endocrinology and Metabolism, 3rd ed. Philadelphia PA: Lippincott Williams & Wilkins; 2002. p.37. Mah PM, Webster J. Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 2002;20:365–74. [CrossRef] Colao A, Savastano S. Medical treatment of prolactinomas. Nat Rev Endocrinol 2011;7:267–78. [CrossRef] Verhelst J, Abs R. Hyperprolactinemia: pathophysiology and management. Treat Endocrinol 2003;2:23–32. [CrossRef] Mancini T, Casanueva FF, Giustina A. Hyperprolactinemia and prolactinomas. Endocrinol Metab Clin North Am 2008;37:67– 99. [CrossRef] Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med 1999;44(Suppl 12):1085–90.
  2. Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, et al. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Arch Neurol 2006;63:729. [CrossRef] Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE. The prevalence of pituitary adenomas: a systematic review. Cancer 2004;101:613–9. [CrossRef] https:// doi.org/10.1002/cncr.20412 Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res 2003;15:373–7. [CrossRef] Studer LH, Aylwin AS. Elevated prolactin levels among adult male sex offenders. Psychol Rep 2006;98:841–8. [CrossRef] Bolyakov A, Paduch DA. Prolactin in men’s health and disease. Curr Opin Urol 2011;21:527–34. [CrossRef] Zolbanin NM, Zolali E, Nayebi AM. Testosterone replacement attenuates haloperidol-induced catalepsy in male rats. Adv Pharm Bull 2014;4:237–41. [CrossRef] Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, et al. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med 2007;4:1485–93. [CrossRef] Maggi M, Buvat J, Corona G, Guay A, Torres LO. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). J Sex Med 2013;10:661–77. [CrossRef] Zeitlin SI, Rajfer J. Hyperprolactinemia and erectile dysfunction. Rev Urol 2000;2:39–42.
  3. Peuskens J, Pani L, Detraux J, De Hert M. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review. CNS Drugs 2014;28:421–53. [CrossRef] Smith S, Wheeler MJ, Murray R, O’Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamicpituitary-gonadal axis. J Clin Psychopharmacol 2002;22